“…This study, however, is limited to a particular district. Globally, studies have revealed that uptake of at least two doses of IPTp-SP is associated with number of ANC visits [5,21,[29][30][31][32][33][34][35][36][37][38], directly observed therapy (DOT) [5,29,37,39,40], residential area [21,29,41], age of woman [41], education level and socioeconomic status [42], parity [5,41], timing of initial ANC visit [5,36,43], knowledge about malaria/IPTp-SP [5,37] and stockouts of the commodity [5,37,44]. This study aimed to contribute to identifying factors associated with completion of recommended doses of SP during pregnancy using the updated WHO policy in resource limited settings from a nationally representative sample.…”